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SummaRy In recent years, group G Streptococcus has been reported with in-
creasing frequency as the cause of a variety of human infections. Underlying host 
factors such as immunosuppression, malignancy, diabetes mellitus, and rheuma-
toid arthritis may be predisposing conditions leading to infection. Toxic involve-
ment and post-streptococcal sequalae, once believed to be exclusive to infec-
tions caused by group A Streptococcus, are now known to occur following acute 
group G Streptococcus and group C Streptococcus infections. We report on a case 
of group G Streptococcus bacteremia and recurrent cellulitis with toxic involve-
ment. Patient blood cultures were always negative for β-hemolytic Streptococci 
in all the recurrences, except during the last one. Antibiotic therapy based on an-
tibiogram quickly resolved the infection. A regimen of intramuscular injection of 
1.2 million units of benzathine penicillin every 15 days for one year prevented 
recurrences of cellulitis.
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IntRoduCtIon
Streptococci are Gram-positive, catalase-nega-
tive cocci characteristically arranged in chains (1). The 
Lancefield Group antigens have been the traditional 
basis for routine classification of Streptococci, and 
most laboratories still use them. There are at least 18 
classified species of streptococci (A to R). Groups A, B, 
C, D, and G are most often involved in human diseas-
es. Group G Streptococci (GGS) are part of the normal 
microbial flora of the pharynx, gastrointestinal tract, 
vagina, and skin (2). In recent years GGS have been 
reported with increasing frequency as the cause of 
a variety of human infections, such as pharyngitis, 
cellulitis, meningitis, endocarditis, and sepsis (3,4,5). 
Bacteremia due to GGS has been strictly related to 
underlying host factors such as immunosuppression, 
malignancy and its treatments, diabetes mellitus, 
bone and joint diseases, cirrhosis, alcoholism, intra-
venous substance abuse, and breakdown of the skin 
(2-4,6,7). 
Bacterial, non-necrotizing cellulitis is a localized 
and deep infection of the skin usually presenting 
with a high fever and the tendency to recur (1). The 
predominant infection site is on the lower extremi-
ties, while the face or arms are more rarely affected. 
Group A Streptococcus (GAS) was considered for a 
long time to be the main causative agent of that in-
fection, although recently Streptococci of group G 
(GGS), group C (GCS), group B and, most rarely, staph-
ylococci emerged as involved in the disease depend-
ing on specific epidemiological situations and/or risk 
factors (9). We report on a case of a female patient 
who developed GGS bacteremia and recurrent cellu-
litis with a toxic involvement.
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CaSe RepoRt
A 66 year-old woman affected by diabetes mel-
litus, obesity, and stage III (pT2, N1, Mx) squamous 
cell carcinoma of the vulva underwent radical vulvec-
tomy, bilateral inguinal femoral nodal dissection and 
postoperative radiation two years prior to admission 
to our Department. The patient was referred with a 
three day history of fever, shivers, vomit, and buttock 
pain with swelling. She also developed a concomi-
tant warm, erythematous rash on the regions of hip 
and both the upper thighs (Fig. 1a, Fig. 1b). She did 
not report any recent injury. She recalled five similar 
episodes involving the same body area with the same 
clinical manifestations, including two recorded events 
at our Institute. In each previous episode no positive 
blood cultures were detected, acute deep thrombosis 
was excluded by Doppler ultrasound, and the patient 
returned to normal healthy condition after empirical 
intravenous antibiotics. On admission, the patient 
was pyrexial (40 ºC) with tachycardic heart rate and 
malaise. An extensive area of warm erythema and 
edema involved the skin of the mid abdomen, the 
upper regions of the thighs, and the buttocks. Labo-
ratory findings referred leukocytosis of 23.700/mm³ 
and the blood culture was GGS positive. During the 
previous episode, the blood-agar Petri dish showed 
the presence of cocci characteristically arranged in 
chains (Fig. 2) and an agglutination test showed a 
positive reaction for group G Lancefield antigens (Fig. 
3). On the basis of blood culture and the antibiogram, 
intravenous amoxicillin 1000 mg and clavulanate 200 
mg were administered every eight hours. The clinical 
condition of the woman improved within a few days, 
the fever decreased, and the skin involvement rap-
idly reduced. Repeated blood cultures were negative. 
Pharyngeal, vaginal, and anal cultures were all nega-
tive for GGS. The patient was discharged after 10 days 
of therapy with clinical resolution. It was decided to 
introduce a regimen of intramuscular injection of 1.2 
million units benzathine penicillin every 15 days for 
one year in order to prevent such recurrent episodes 
of cellulitis. One year after hospital discharge, the pa-
tient has not developed any further symptoms.
dISCuSSIon
Severe invasive soft tissue infection, toxin produc-
tion, or recurrent infections were once believed to be 
exclusive to infections caused by GAS. More recently, 
a stronger role of GGS has been noticed in cellulitis 
(7) and, with increasing frequency, in nonfocal bacte-
remia (4). Cellulitis is in fact more common in people 
with underlying venous and lymphatic impairment, 
and, in particular when recurrent, it is often associated 
with significant morbidity (9). Our patient had long-
standing predisposing disorders that led to a major 
impairment of lymphatic circulation. During the last 
hospitalization, our patient presented with a specific 
toxic involvement due to GGS bacteremia, confirm-
ing that toxin-peptides production is not exclusively 
a GAS-associated trait but also concerns other groups 
Figure 1a and 1b. Erythematous rash 
on hips and upper thighs
Figure 2. Blood-agar Petri dish; the presence of cocci 
characteristically arranged in chains. 
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of Streptococci. In each previous episodes of cellu-
litis no positive blood cultures were detected. Even 
though in case of these infections it is recommended 
to perform culture from skin and soft tissue samples, 
the utility of blood cultures remains controversial due 
to the low frequency of positive results, as confirmed 
by the literature (1,6). 
Although serious community-acquired GGS infec-
tions occur with increasing frequency (6), they remain 
rare. The pathogen’s persistence in the tissue, despite 
antibiotic treatment, contributes to the rate of recur-
rence. A previous episode of cellulitis seems to be a 
strong predisposing factor to future episodes (3,8). 
Various general and local risk factors play a role in re-
currence, as does the patient’s increased susceptibil-
ity to infection, such as the inability of the immune 
system to clear the bacteria from the infection site (9). 
When treating this infection it is therefore crucial to 
recognize the underlying comorbidity and to make a 
targeted diagnosis with both serial blood cultures and 
an agglutination test so as to choose the appropriate 
prophylactic antibiotic treatment in order to prevent 
relapses. Prompt treatment with appropriate antibi-
otics appears universally successful. Benzylpenicillin 
has been the mainstay of this treatment, although 
some patients are  slow responders and may need a 
second antibiotic, such as clindamycin or gentamicin 
(10). 
ConCuSIon
 Finally, it is necessary to take into account that a 
Streptococcal septicaemia or an extensive spread of 
cellulitis in a patient with many comorbidities may, 
despite adequate antibiotic therapy, progress to mul-
tiple-organ failure and death (8,10).
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Figure 3. Agglutination test; a positive reaction for 
the group G Lancefield antigens.
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